A groundbreaking multinational clinical trial, named RESILIENCE, is underway to test a promising new treatment aimed at ...

Dapagliflozin reduced the risk of all-cause mortality or worsening heart failure by 28% in patients with aortic stenosis ...

The past 12 months mark a milestone year for the discipline of sports and exercise cardiology.We have seen the publication of two major guideline documents for athletes: the 2025 American Heart Associ ...

Migraine treatment with topiramate is linked to lower risks of end-stage kidney disease (ESKD), death, and ventricular arrhythmia/cardiac arrest, an investigator reported at the 62 nd European Renal ...

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, ...

The global automated external defibrillators (AED) market, valued at approximately USD 0.81 billion in 2022, is expected to grow at a healthy compound annual growth rate (CAGR) of more than 8.78% from ...

Heart attacks are no longer the leading cause of heart disease-related death, but deaths from heart disease have still been ...

Kolkata: Eastern India's first-ever case of Bachmann's Bundle (BB) Pacing and Left Bundle Branch Area Pacing (LBBAP), a dual strategy that mimics the .

Cardiac arrest, a sudden cessation of heart function, demands immediate intervention to prevent death. Survival rates, ...

At the AAA Conference, Dr. Long delivered more than a keynote — she issued a survival plan for first responders facing ...

Previous knowledge on melatonin use for pulmonary arterial hypertension has primarily been gathered from animal studies, with ...

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.